Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection

Abstract Type I Interferons (IFN-I) are central to host protection against viral infections, with plasmacytoid dendritic cells (pDC) being the most significant source, yet pDCs lose their IFN-I production capacity following an initial burst of IFN-I, resulting in susceptibility to secondary infectio...

Full description

Saved in:
Bibliographic Details
Main Authors: Trever T. Greene, Yeara Jo, Carolina Chiale, Monica Macal, Ziyan Fang, Fawziyah S. Khatri, Alicia L. Codrington, Katelynn R. Kazane, Elizabeth Akbulut, Shobha Swaminathan, Yu Fujita, Patricia Fitzgerald-Bocarsly, Thekla Cordes, Christian Metallo, David A. Scott, Elina I. Zúñiga
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-56603-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861805216169984
author Trever T. Greene
Yeara Jo
Carolina Chiale
Monica Macal
Ziyan Fang
Fawziyah S. Khatri
Alicia L. Codrington
Katelynn R. Kazane
Elizabeth Akbulut
Shobha Swaminathan
Yu Fujita
Patricia Fitzgerald-Bocarsly
Thekla Cordes
Christian Metallo
David A. Scott
Elina I. Zúñiga
author_facet Trever T. Greene
Yeara Jo
Carolina Chiale
Monica Macal
Ziyan Fang
Fawziyah S. Khatri
Alicia L. Codrington
Katelynn R. Kazane
Elizabeth Akbulut
Shobha Swaminathan
Yu Fujita
Patricia Fitzgerald-Bocarsly
Thekla Cordes
Christian Metallo
David A. Scott
Elina I. Zúñiga
author_sort Trever T. Greene
collection DOAJ
description Abstract Type I Interferons (IFN-I) are central to host protection against viral infections, with plasmacytoid dendritic cells (pDC) being the most significant source, yet pDCs lose their IFN-I production capacity following an initial burst of IFN-I, resulting in susceptibility to secondary infections. The underlying mechanisms of these dynamics are not well understood. Here we find that viral infection reduces the capacity of pDCs to engage both oxidative and glycolytic metabolism. Mechanistically, we identify lactate dehydrogenase B (LDHB) as a positive regulator of pDC IFN-I production in mice and humans; meanwhile, LDHB deficiency is associated with suppressed IFN-I production, pDC metabolic capacity, and viral control following infection. In addition, preservation of LDHB expression is sufficient to partially retain the function of otherwise exhausted pDCs, both in vitro and in vivo. Furthermore, restoring LDHB in vivo in pDCs from infected mice increases IFNAR-dependent, infection-associated pathology. Our work thus identifies a mechanism for balancing immunity and pathology during viral infections, while also providing insight into the highly preserved infection-driven pDC inhibition.
format Article
id doaj-art-5b08216b5e0049c599210f9c2d60e07b
institution Kabale University
issn 2041-1723
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-5b08216b5e0049c599210f9c2d60e07b2025-02-09T12:46:24ZengNature PortfolioNature Communications2041-17232025-02-0116111910.1038/s41467-025-56603-5Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infectionTrever T. Greene0Yeara Jo1Carolina Chiale2Monica Macal3Ziyan Fang4Fawziyah S. Khatri5Alicia L. Codrington6Katelynn R. Kazane7Elizabeth Akbulut8Shobha Swaminathan9Yu Fujita10Patricia Fitzgerald-Bocarsly11Thekla Cordes12Christian Metallo13David A. Scott14Elina I. Zúñiga15Department of Biological Sciences, University of California, San DiegoDepartment of Biological Sciences, University of California, San DiegoDepartment of Biological Sciences, University of California, San DiegoDepartment of Biological Sciences, University of California, San DiegoDepartment of Biological Sciences, University of California, San DiegoDepartment of Biological Sciences, University of California, San DiegoDepartment of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical SchoolDepartment of Biological Sciences, University of California, San DiegoDepartment of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical SchoolDepartment of Medicine, Division of Infectious Disease, The State University of New Jersey, Rutgers, New Jersey Medical SchoolDivision of Next-Generation Drug Development, Research Center for Medical Sciences, The Jikei University School of MedicineDepartment of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical SchoolDepartment of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität BraunschweigMolecular and Cell Biology Laboratory, Salk Institute for Biological SciencesCancer Center, Sanford Burnham Prebys Medical Discovery InstituteDepartment of Biological Sciences, University of California, San DiegoAbstract Type I Interferons (IFN-I) are central to host protection against viral infections, with plasmacytoid dendritic cells (pDC) being the most significant source, yet pDCs lose their IFN-I production capacity following an initial burst of IFN-I, resulting in susceptibility to secondary infections. The underlying mechanisms of these dynamics are not well understood. Here we find that viral infection reduces the capacity of pDCs to engage both oxidative and glycolytic metabolism. Mechanistically, we identify lactate dehydrogenase B (LDHB) as a positive regulator of pDC IFN-I production in mice and humans; meanwhile, LDHB deficiency is associated with suppressed IFN-I production, pDC metabolic capacity, and viral control following infection. In addition, preservation of LDHB expression is sufficient to partially retain the function of otherwise exhausted pDCs, both in vitro and in vivo. Furthermore, restoring LDHB in vivo in pDCs from infected mice increases IFNAR-dependent, infection-associated pathology. Our work thus identifies a mechanism for balancing immunity and pathology during viral infections, while also providing insight into the highly preserved infection-driven pDC inhibition.https://doi.org/10.1038/s41467-025-56603-5
spellingShingle Trever T. Greene
Yeara Jo
Carolina Chiale
Monica Macal
Ziyan Fang
Fawziyah S. Khatri
Alicia L. Codrington
Katelynn R. Kazane
Elizabeth Akbulut
Shobha Swaminathan
Yu Fujita
Patricia Fitzgerald-Bocarsly
Thekla Cordes
Christian Metallo
David A. Scott
Elina I. Zúñiga
Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection
Nature Communications
title Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection
title_full Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection
title_fullStr Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection
title_full_unstemmed Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection
title_short Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection
title_sort metabolic deficiencies underlie reduced plasmacytoid dendritic cell ifn i production following viral infection
url https://doi.org/10.1038/s41467-025-56603-5
work_keys_str_mv AT trevertgreene metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT yearajo metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT carolinachiale metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT monicamacal metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT ziyanfang metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT fawziyahskhatri metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT alicialcodrington metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT katelynnrkazane metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT elizabethakbulut metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT shobhaswaminathan metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT yufujita metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT patriciafitzgeraldbocarsly metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT theklacordes metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT christianmetallo metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT davidascott metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection
AT elinaizuniga metabolicdeficienciesunderliereducedplasmacytoiddendriticcellifniproductionfollowingviralinfection